Verteporfin: A Review of its Use in the Management of Subfoveal Choroidal Neovascularisation

By Keam S.J.   Scott L.J.   Curran M.P.  

Drugs, Vol. 63, Iss. 22, 2003-01 ,pp. : 2521-2554

Adis International

Access to resources Recommend Favorite

Spotlight on Verteporfin in Subfoveal Choroidal Neovascularisation

By Keam S.J.   Scott L.J.   Curran M.P.  

Drugs & Aging, Vol. 21, Iss. 3, 2004-01 ,pp. : 203-209

Adis International

Access to resources Recommend Favorite

Pharmacogenetic Aspects in Therapeutic Management of Subfoveal Choroidal Neovascularisation: Role of Factor XIII-A 185 T-Allele

By  

Current Drug Targets, Vol. 12, Iss. 2, 2011-02 ,pp. : 138-148

Bentham Science Publishers

Access to resources Recommend Favorite

Verteporfin: Aggravation of choroidal neovascularisation in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1414, 2012-01 ,pp. : 48-49

Adis International

Access to resources Recommend Favorite

Safety of verteporfin for treatment of subfoveal choroidal neovascular membranes associated with age-related macular degeneration

By Gaynes Bruce I   Fiscella Richard G  

Expert Opinion on Drug Safety, Vol. 3, Iss. 4, 2004-07 ,pp. : 345-361

Informa Healthcare

Access to resources Recommend Favorite